Yolanda S. Kap

1.2k total citations
33 papers, 872 citations indexed

About

Yolanda S. Kap is a scholar working on Immunology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Yolanda S. Kap has authored 33 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 19 papers in Pathology and Forensic Medicine and 8 papers in Rheumatology. Recurrent topics in Yolanda S. Kap's work include Immunotherapy and Immune Responses (18 papers), Multiple Sclerosis Research Studies (17 papers) and T-cell and B-cell Immunology (13 papers). Yolanda S. Kap is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Multiple Sclerosis Research Studies (17 papers) and T-cell and B-cell Immunology (13 papers). Yolanda S. Kap collaborates with scholars based in Netherlands, Austria and United Kingdom. Yolanda S. Kap's co-authors include Bert A. ‘t Hart, Jon D. Laman, S. Anwar Jagessar, Jan Bauer, Nikki van Driel, Erwin L. A. Blezer, Herbert Brok, Eric Fliers, Johannes A. Romijn and Hans P. Sauerwein and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yolanda S. Kap

33 papers receiving 868 citations

Peers

Countries citing papers authored by Yolanda S. Kap

Since Specialization

Citations

This map shows the geographic impact of Yolanda S. Kap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda S. Kap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda S. Kap more than expected).

Fields of papers citing papers by Yolanda S. Kap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda S. Kap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda S. Kap. The network helps show where Yolanda S. Kap may publish in the future.

Co-authorship network of co-authors of Yolanda S. Kap

This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda S. Kap. A scholar is included among the top collaborators of Yolanda S. Kap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda S. Kap. Yolanda S. Kap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge 2023 ·Scientific Reports ·Gerrit Koopman, Mario Amacker, Toon Stegmann, Ernst J. Verschoor, Babs E. Verstrepen, (unknown), (unknown), Kinga P. Böszörményi, Zahra Fagrouch, (unknown), Daniëlla Mortier, (unknown), Henk Niphuis, (unknown), Ivanela Kondova, Yolanda S. Kap, Willy Bogers, Petra Mooij, Sylvain Fleury	3
2	Oxidative Injury and Iron Redistribution Are Pathological Hallmarks of Marmoset Experimental Autoimmune Encephalomyelitis 2017 ·Journal of Neuropathology & Experimental Neurology ·(unknown), Jan Bauer, G. Campbell, Don Mahad, Nikki van Driel, Susanne M. A. van der Pol, Bert A. ‘t Hart, Hans Lassmann, Jon D. Laman, Jack van Horssen, Yolanda S. Kap	26
3	A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model 2017 ·Frontiers in Immunology ·Bert A. ‘t Hart, (unknown), Bart W. Faber, Jon D. Laman, Jack van Horssen, Jan Bauer, Yolanda S. Kap	16
4	EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model 2016 ·Trends in Molecular Medicine ·(unknown), Yolanda S. Kap, Elena Morandi, Jon D. Laman, Bruno Gran	34
5	The common marmoset (<i>Callithrix jacchus</i>): a relevant preclinical model of human (auto)immune-mediated inflammatory disease of the brain 2016 ·SHILAP Revista de lepidopterología ·Bert A. ‘t Hart, (unknown), S. Anwar Jagessar, Yolanda S. Kap	1
6	Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis 2015 ·Clinical & Experimental Immunology ·Michel Vierboom, (unknown), Yolanda S. Kap, Caroline Mary, Nicolas Poirier, Bert A. ‘t Hart, Bernard Vanhove	20
7	Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis 2015 ·Journal of Neuroimmune Pharmacology ·(unknown), Li‐Fen Lee, Nikki van Driel, Jon D. Laman, Irene Ni, Wenwu Zhai, (unknown), John Lin, Jan Bauer, Bert A. ‘t Hart, Yolanda S. Kap	18
8	Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies 2014 ·Drug Discovery Today ·Bert A. ‘t Hart, S. Anwar Jagessar, Yolanda S. Kap, Krista G. Haanstra, Ingrid H.C.H.M. Philippens, Ché Serguera, Jan A. M. Langermans, Michel Vierboom	14
9	Experimental Autoimmune Encephalomyelitis in Marmosets 2014 ·Methods in molecular biology ·S. Anwar Jagessar, Karin Dijkman, (unknown), Bert A. ‘t Hart, Yolanda S. Kap	6
10	Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species 2013 ·Journal of Neuroimmune Pharmacology ·Krista G. Haanstra, S. Anwar Jagessar, Anne-Laure Bauchet, (unknown), Claire-Maëlle Fovet, Nicole Heijmans, Sam Hofman, (unknown), Jeffrey J. Bajramović, Yolanda S. Kap, Jon D. Laman, (unknown), (unknown), Jan Bauer, F. Lachapelle, Ché Serguera, Bert A. ‘t Hart	39
11	The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis 2013 ·Frontiers in Immunology ·Bert A. ‘t Hart, S. Anwar Jagessar, Krista G. Haanstra, Ernst J. Verschoor, Jon D. Laman, Yolanda S. Kap	43
12	B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis 2011 ·Journal of Neuropathology & Experimental Neurology ·Yolanda S. Kap, Jan Bauer, Nikki van Driel, Wim K. Bleeker, Paul W.H.I. Parren, Evert‐Jan Kooi, Jeroen J.G. Geurts, Jon D. Laman, Jenny Craigen, Erwin L. A. Blezer, Bert A. ‘t Hart	29
13	Effects of Early IL-17A Neutralization on Disease Induction in a Primate Model of Experimental Autoimmune Encephalomyelitis 2010 ·Journal of Neuroimmune Pharmacology ·Yolanda S. Kap, S. Anwar Jagessar, Nikki van Driel, Erwin L. A. Blezer, Jan Bauer, Marjan van Meurs, Paul A. Smith, Jon D. Laman, Bert A. ‘t Hart	23
14	Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG_34-56Peptide in Incomplete Freund Adjuvant 2010 ·Journal of Neuropathology & Experimental Neurology ·S. Anwar Jagessar, Yolanda S. Kap, Nicole Heijmans, Nikki van Driel, (unknown), Jeffrey J. Bajramović, Herbert Brok, Erwin L. A. Blezer, Jan Bauer, Jon D. Laman, Bert A. ‘t Hart	64
15	Synthetic Human Chorionic Gonadotropin–Related Oligopeptides Impair Early Innate Immune Responses toListeria monocytogenesin Mice 2010 ·The Journal of Infectious Diseases ·Marten van der Zee, Willem A. Dik, Yolanda S. Kap, Marilyn J. Dillon, Robbert Benner, Pieter J. M. Leenen, Nisar Khan, Douglas A. Drevets	16
16	Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development 2009 ·Journal of Neuroimmune Pharmacology ·Yolanda S. Kap, Jon D. Laman, Bert A. ‘t Hart	48
17	Preclinical models of multiple sclerosis in nonhuman primates 2007 ·Expert Review of Clinical Immunology ·Bert A. ‘t Hart, S. Anwar Jagessar, Yolanda S. Kap, Herbert Brok	4
18	Pin1 levels are downregulated during ER stress in human neuroblastoma cells 2006 ·Neurogenetics ·Yolanda S. Kap, Jeroen J.M. Hoozemans, (unknown), Rob Zwart, Onno C. Meijer, Frank Baas, Wiep Scheper	3
19	The human CMV-UL86 peptide 981–1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34–56, but lacks the capacity to induce EAE in rhesus monkeys 2006 ·Journal of Neuroimmunology ·Herbert Brok, Leonie A. Boven, Marjan van Meurs, Nicole Kerlero de Rosbo, A Paul, Yolanda S. Kap, (unknown), Rogier Q. Hintzen, Geoff Keir, Jeffrey J. Bajramović, Avraham Ben‐Nun, Jan Bauer, Jon D. Laman, Sandra Amor, Bert A. ‘t Hart	42
20	Tracing from Fat Tissue, Liver, and Pancreas: A Neuroanatomical Framework for the Role of the Brain in Type 2 Diabetes 2005 ·Endocrinology ·Felix Kreier, Yolanda S. Kap, Thomas C. Mettenleiter, Caroline van Heijningen, Jan van der Vliet, Andries Kalsbeek, Hans P. Sauerwein, Eric Fliers, Johannes A. Romijn, Ruud M. Buijs	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact